Xcell Therapeutics Inc.

KOSDAQ:A373110 Stock Report

Market Cap: ₩65.2b

Xcell Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A373110?
Owner TypeNumber of SharesOwnership Percentage
Public Companies210,5261.93%
VC/PE Firms604,0805.53%
Private Companies1,384,58712.7%
Individual Insiders1,999,56418.3%
General Public6,719,70561.5%

Dilution of Shares: A373110 only recently listed within the past 12 months


Top Shareholders

Top 8 shareholders own 38.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.8%
Ui-Il Lee
1,719,564₩10.3b0%no data
5.53%
Korea Investment Partners Co. Ltd.
604,080₩3.6b0%1.57%
4.44%
APRJD Biomaterial New Technology Association No. 1
485,182₩2.9b0%no data
3.81%
Ignite Innovators Co., Ltd.
416,284₩2.5b0%no data
3.19%
Jw Asset Co., Ltd.
348,369₩2.1b0%no data
2.56%
Hyun-Jung Jung
280,000₩1.7b0%no data
1.93%
Daesang Corporation
210,526₩1.3b0%no data
1.23%
W Bio Co., Ltd.
134,752₩804.5m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.